www.globaldata.com
Open in
urlscan Pro
52.48.140.29
Public Scan
Submitted URL: https://go.pardot.com/e/375012/Email-IVD-Market-18-12-23-EM01/6snts1/5614275903/h/YZjQbcUt14AgYhj7_wHrH4eoBvxXcU2rMxo7...
Effective URL: https://www.globaldata.com/store/report/in-vitro-diagnostics-market-analysis/?utm_source=email&utm_medium=campaign&utm_camp...
Submission: On December 14 via manual from US — Scanned from DE
Effective URL: https://www.globaldata.com/store/report/in-vitro-diagnostics-market-analysis/?utm_source=email&utm_medium=campaign&utm_camp...
Submission: On December 14 via manual from US — Scanned from DE
Form analysis 5 forms found in the DOM
GET https://www.globaldata.com/store/
<form action="https://www.globaldata.com/store/" method="get" id="solr_facet">
<div class="main-menu-report">
<div class="input-group search">
<input type="text" class="input-group-field ui-autocomplete-input search" tabindex="1" id="main_search_field" name="s" placeholder="Search" autocomplete="off" value="">
<div class="input-group-button">
<button type="submit" class="button" id="btncompanyname"><i class="gd-ico gd-magnif"></i>
</button>
</div>
</div>
</div>
</form><form novalidate="">
<fieldset class="price_sec">
<div class="subscription-level">
<div class="form-radio ">
<input id="radio_subscription-single" name="radio_subscription-level" value="3248222" type="radio">
<label for="radio_subscription-single">Single User</label>
</div>
<span data-tooltip="" title="" aria-describedby="c41w1o-tooltip" data-yeti-box="c41w1o-tooltip" data-toggle="c41w1o-tooltip" data-resize="c41w1o-tooltip" class="has-tip" data-e="0nvebk-e"><i class="gd-ico gd-info"></i></span>
<!-- <div class="price"><span>$3,995</span><span class="discount">$3,995</span><span class="discount-off">(20% off)</span></div> -->
<div class="price"><span class="woocommerce-Price-amount"><span class="woocommerce-Price-amount amount"><bdi><span class="woocommerce-Price-currencySymbol">$</span>3,950</bdi></span></span> <span data-price="500000"
class="js-hide local-price js-local-price" style="display: none;"></span></div>
</div>
<p>Can be used by individual purchaser only</p>
</fieldset>
<fieldset class="popular price_sec">
<legend>Most Popular</legend>
<div class="subscription-level">
<div class="form-radio ">
<input id="radio_subscription-multi" name="radio_subscription-level" value="3248223" type="radio" checked="">
<label for="radio_subscription-multi">Multi-users</label>
</div>
<span data-tooltip="" title="" aria-describedby="i9awyp-tooltip" data-yeti-box="i9awyp-tooltip" data-toggle="i9awyp-tooltip" data-resize="i9awyp-tooltip" class="has-tip" data-e="jtpeng-e"><i class="gd-ico gd-info"></i></span>
<div class="price"><span class="woocommerce-Price-amount"><span class="woocommerce-Price-amount amount"><bdi><span class="woocommerce-Price-currencySymbol">$</span>5,950</bdi></span></span> <span data-price="500000"
class="js-hide local-price js-local-price" style="display: none;"></span></div>
</div>
<p>Can be shared by unlimited users within one corporate location e.g. a regional office</p>
</fieldset>
<fieldset class="price_sec">
<div class="subscription-level">
<div class="form-radio ">
<input id="radio_subscription-enterprise" name="radio_subscription-level" value="3248221" type="radio">
<label for="radio_subscription-enterprise">Enterprise</label>
</div>
<span data-tooltip="" title="" aria-describedby="fsamzp-tooltip" data-yeti-box="fsamzp-tooltip" data-toggle="fsamzp-tooltip" data-resize="fsamzp-tooltip" class="has-tip" data-e="4m213o-e"><i class="gd-ico gd-info"></i></span>
<div class="price"><span class="woocommerce-Price-amount"><span class="woocommerce-Price-amount amount"><bdi><span class="woocommerce-Price-currencySymbol">$</span>7,950</bdi></span></span> <span data-price="500000"
class="js-hide local-price js-local-price" style="display: none;"></span></div>
</div>
<p>Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company</p>
</fieldset>
</form><form class="gs3k"><textarea placeholder="Write a message…" spellcheck="true" rows="1" enterkeyhint="send" class="gs20 gs3l" style="height: 0px;"></textarea><input type="file" multiple="" class="gs3j"><button class="gs21 gs21_1 gs3m gs3p gs3n"><svg
width="16" height="16" viewBox="0 0 16 16" fill="none" xmlns="http://www.w3.org/2000/svg">
<rect width="16" height="16" fill="none"></rect>
<path fill-rule="evenodd" clip-rule="evenodd"
d="M8 3C7.44772 3 7 3.44772 7 4V7L4 7C3.44772 7 3 7.44771 3 8C3 8.55228 3.44772 9 4 9H7V12C7 12.5523 7.44772 13 8 13C8.55228 13 9 12.5523 9 12V9H12C12.5523 9 13 8.55228 13 8C13 7.44772 12.5523 7 12 7L9 7V4C9 3.44772 8.55228 3 8 3Z"
fill="black" class="gsac"></path>
</svg></button><button class="gs21 gs21_2 gs3m gs3q"><svg width="16" height="16" viewBox="0 0 16 16" fill="none" xmlns="http://www.w3.org/2000/svg">
<path fill-rule="evenodd" clip-rule="evenodd"
d="M8.63965 3.53354C8.2688 3.2245 7.73013 3.2245 7.35928 3.53354L4.12133 6.23183C3.40282 6.83059 3.82622 8 4.76151 8H7V12C7 12.5523 7.44718 13 8 13C8.55175 13 9 12.5523 9 12V8H11.2374C12.1727 8 12.5961 6.83059 11.8776 6.23183L8.63965 3.53354Z"
fill="black" class="gsac"></path>
</svg></button></form><form class="gs1n"><input type="email" placeholder="Email Address" required="" class="gs1p"><textarea placeholder="Write a message…" required="" class="gs20 gs1p gs1q" style="height: 0px;"></textarea><button class="gs21 gs21_3 gs1r">Submit</button>
</form><form class="gs3k"><textarea placeholder="Write a message…" spellcheck="true" disabled="" rows="1" enterkeyhint="send" class="gs20 gs3l" style="height: 0px;"></textarea><input type="file" multiple="" class="gs3j"><button
class="gs21 gs21_4 gs3m gs3p gs3n"><svg width="16" height="16" viewBox="0 0 16 16" fill="none" xmlns="http://www.w3.org/2000/svg">
<rect width="16" height="16" fill="none"></rect>
<path fill-rule="evenodd" clip-rule="evenodd"
d="M8 3C7.44772 3 7 3.44772 7 4V7L4 7C3.44772 7 3 7.44771 3 8C3 8.55228 3.44772 9 4 9H7V12C7 12.5523 7.44772 13 8 13C8.55228 13 9 12.5523 9 12V9H12C12.5523 9 13 8.55228 13 8C13 7.44772 12.5523 7 12 7L9 7V4C9 3.44772 8.55228 3 8 3Z"
fill="black" class="gsac"></path>
</svg></button><button class="gs21 gs21_5 gs3m gs3q"><svg width="16" height="16" viewBox="0 0 16 16" fill="none" xmlns="http://www.w3.org/2000/svg">
<path fill-rule="evenodd" clip-rule="evenodd"
d="M8.63965 3.53354C8.2688 3.2245 7.73013 3.2245 7.35928 3.53354L4.12133 6.23183C3.40282 6.83059 3.82622 8 4.76151 8H7V12C7 12.5523 7.44718 13 8 13C8.55175 13 9 12.5523 9 12V8H11.2374C12.1727 8 12.5961 6.83059 11.8776 6.23183L8.63965 3.53354Z"
fill="black" class="gsac"></path>
</svg></button></form>Text Content
REPORT STORE
* Visit Corporate Site
* Sign In
Menu
* REPORT STORE
* Sign in
* Home
* REPORTS
View all Reports
REPORTS BY SECTOR
* Aerospace and Defense
* Agriculture and Forestry
* Apparel
* Automotive
* Business and Consumer Services
* Chemicals
* Construction
* Consumer
* COVID-19
* Financial Services
* Foodservice
* Government and Non-Profit Organisations
* Industrial Goods and Machinery
* Medical Devices
* Mining
* Oil and Gas
* Packaging
* Pharmaceuticals
* Power
* Retail
* Sport
* Technology
* Telecommunications
* Transportation, Infrastructure and Logistics
* Travel and Tourism
REPORT TYPE
* Company Profile
* Track & Monitor
* Sector Analysis
* Product Insights
* Analyst Opinions
* Company Insights
* Thematic Analysis
* Case Studies
* Visit Corporate Site
* Home
* Reports
* Current: Medical Devices
* Current: In Vitro Diagnostics
3248220 1 Blockbuster
IN-VITRO DIAGNOSTICS (IVD) MARKET SIZE, SHARE AND TRENDS ANALYSIS BY REGION,
PRODUCT AND SEGMENT FORECAST TO 2033
Powered by
Access in-depth insight and stay ahead of the market
$3950
Buy Report View Sample
Published: October 25, 2023 Report Code: GRCBBR00005ME-BB
Share
* Share on Twitter
* Share on LinkedIn
* Share on Facebook
* Share via Email
* Copy Link
Report Overview
* Report Overview
* Key Players
* Table of Contents
* Table
* Figures
* FAQs
Accessing the in-depth insights from the ‘In Vitro Diagnostics’ report can help:
* Gain a valuable understanding of the current and future state of the market,
allowing businesses to make informed decisions about market entry, product
development, and investments.
* Identify competitors’ capabilities to stay ahead in the market.
* Identify segments and get an understanding of various stakeholders.
* Anticipate changes in demand and adjust business development strategies.
* Identify potential regions and countries for growth opportunities.
How is our ‘In Vitro Diagnostics’ report different from other reports in the
market?
* The report presents in-depth market sizing and forecasts at a segment level
for more than 25 countries, including historical and forecast analysis for
2021-2033 for market assessment.
* Detailed segmentation by:
* * Product – COVID-19 Tests, Cholesterol Tests, Colorectal Cancer Screening
Tests, Hepatitis B Tests, Hepatitis C Tests, Clinical Chemistry Analyzers,
Hematology Tests, Human Immunodeficiency Virus (HIV) Tests, Immunochemistry
Analyzers, Diabetes Assays, and Others
* Region – North America, Europe, Asia-Pacific, South & Central America, and
Middle East & Africa
* The report covers the key market drivers and challenges impacting the IVD
market.
* The competitive landscape includes an overview and company share analysis by
segment in the IVD market that will help the stakeholders in the ongoing
process of identifying, researching, and evaluating competitors, to gain
insight to form their business strategies.
* Competitive profiling and benchmarking of key companies in the market to
provide a deeper understanding of industry competition.
We recommend this valuable source of information to:
* Companies Offering IVD Solutions
* Consulting & Professional Services Firms
* Researchers and Academics
* Venture Capital/Equity Firms
To Get a Snapshot of the IVD Market Report, Download a Free Sample
IN VITRO DIAGNOSTICS (IVD) MARKET OVERVIEW
The in vitro diagnostics (IVD) market will be valued at $60.3 billion in 2023 at
a compound annual growth rate (CAGR) of -5.3% over the forecast period. The in
vitro diagnostics market refers to the commercial sector related to the
production, distribution, sale, and services associated with IVD equipment and
technologies.
The in vitro diagnostics (IVD) market is a critical segment of the healthcare
industry that encompasses a wide range of tests and diagnostic tools designed to
analyze samples outside the human body. These diagnostics play a fundamental
role in disease detection, monitoring, and personalized medicine. This market’s
products include covid-19 tests, cholesterol tests, colorectal cancer screening
tests, hepatitis B tests, hepatitis C tests, clinical chemistry analyzers,
hematology tests, human immunodeficiency virus (HIV) tests, immunochemistry
analyzers, diabetes assays, and others.
The in vitro diagnostics (IVD) market holds significant importance in the realm
of healthcare, as it plays a critical role in disease diagnosis, treatment
monitoring, and the overall management of patient health. IVD is pivotal in
early disease detection. Timely diagnosis is often the linchpin in successful
treatment and recovery. IVD technologies encompass a wide array of tests that
analyze biological samples such as blood, urine, and tissues outside the human
body. These tests can detect the presence of diseases and health conditions even
before symptoms manifest.
In Vitro Diagnostics (IVD) Market Outlook, 2021 – 2033 ($Billion)
Buy the Full Report for Additional Insights on the IVD Market Forecast
Download a Free Sample
The IVD market is crucial for patient-centered, personalized medicine. It allows
healthcare providers to tailor treatments to individual patients based on their
unique genetic makeup and disease profiles. For instance, genetic testing, a
subset of IVD, can reveal specific genetic mutations that influence how a
patient’s body responds to medications. This information empowers clinicians to
prescribe the most effective drugs and dosages, minimizing adverse reactions and
optimizing therapeutic outcomes. Personalized medicine, made possible by IVD, is
a significant advancement that promises to revolutionize the healthcare
landscape, providing more efficient and effective treatments.
Market Size (2023) $60.3 billion CAGR (2023 – 2033) -5.3% Forecast Period
2023-2033 Historic Data 2021 & 2022 Report Scope & Coverage Industry Overview,
Market Dynamics, Regulatory Landscape, Reimbursement Scenario, Revenue Forecast,
Regional Analysis, Competitive Landscape, Company Profiles Product COVID-19
Tests, Cholesterol Tests, Colorectal Cancer Screening Tests, Hepatitis B Tests,
Hepatitis C Tests, Clinical Chemistry Analyzers, Hematology Tests, Human
Immunodeficiency Virus Tests, Immunochemistry Analyzers, Diabetes Assays, and
Others Regional Segment North America, Europe, Asia-Pacific, Central & South
America, and Middle East & Africa Key Companies Danaher Corp, Abbott
Laboratories, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, and Thermo
Fisher Scientific Inc
IN VITRO DIAGNOSTICS (IVD) MARKET SEGMENTATION BY PRODUCT TYPE
The IVD market by product is segmented into COVID-19 tests, cholesterol tests,
colorectal cancer screening tests, hepatitis B tests, hepatitis C tests,
clinical chemistry analyzers, hematology tests, human immunodeficiency virus
tests, immunochemistry analyzers, diabetes assays, and others. The colorectal
cancer screening tests segment is expected to be the fastest-growing product
segment, with a CAGR of over 6.3% during the forecast period.
Colorectal cancer screening tests hold paramount significance within the in
vitro diagnostics (IVD) market. Colorectal cancer, often referred to as bowel
cancer, is a formidable adversary in the realm of oncology, being one of the
most prevalent and lethal malignancies worldwide. The impact of early detection
and intervention cannot be overstated, and this is where the IVD market’s
colorectal cancer screening segment plays a prominent role in market growth.
One of the most prominent colorectal cancer screening tests is the fecal occult
blood test (FOBT). This simple, non-invasive test detects trace amounts of blood
in the stool, which can be an early sign of colorectal cancer or pre-cancerous
polyps. FOBTs are a cost-effective and efficient method to screen a large
population for potential colorectal cancer risks. They have significantly
reduced mortality rates by identifying cases at an early, treatable stage.
In Vitro Diagnostics (IVD) Market Share by Product Type, 2023 (%)
Buy the Full Report for IVD Product Type Revenues and Shares
Download a Free Sample
The clinical chemistry analyzers segment is the second fastest-growing revenue
share in 2023. Clinical chemistry analyzers are a crucial segment within the
broader field of in vitro diagnostics (IVD), playing a significant role in
modern healthcare. These analyzers are vital tools for diagnosing and monitoring
a wide range of medical conditions by analyzing various substances in bodily
fluids. In a rapidly evolving IVD market, the clinical chemistry analyzers
segment stands out due to its pivotal importance, versatility, and impact on
patient care. This segment not only addresses the need for rapid and accurate
diagnostics but also plays a key role in managing chronic diseases and enhancing
the efficiency of healthcare systems.
The clinical chemistry analyzers segment in the in vitro diagnostics (IVD)
market has immense significance in modern healthcare. Their role in disease
prevention, early detection, and chronic disease management is paramount. With
ongoing technological advancements and the integration of digital technologies,
clinical chemistry analyzers are becoming even more efficient, cost-effective,
and essential tools for healthcare providers.
IN VITRO DIAGNOSTICS (IVD) MARKET ANALYSIS BY REGION
Asia-Pacific is leading the market with a maximum revenue share in 2023 and is
projected to experience a compound annual growth rate of -12.9% over the
forecast period. The in vitro diagnostics (IVD) market in the Asia-Pacific is
one of the most mature markets globally. The Asia-Pacific region encompasses a
wide spectrum of healthcare systems, from highly developed ones in countries
such as Japan and Singapore to emerging healthcare markets in parts of Southeast
Asia.
Prominent companies such as Danaher Corp, Abbott Laboratories, F. Hoffmann-La
Roche Ltd, Bio-Rad Laboratories Inc., and Thermo Fisher Scientific Inc. have a
significant presence in the Asia-Pacific market, supplying advanced IVD
equipment and technologies.
In Vitro Diagnostics (IVD) Market Share by Region, 2023 (%)
Buy the Full Report for Additional IVD Market Insights
Download a Free Sample
Europe holds the second position in the IVD market in terms of revenue share in
2023. The region is projected to witness a CAGR of around -4% over the forecast
period from 2023 to 2033. The European region’s IVD market is characterized by
its diversity, rapid growth, and commitment to leveraging advanced technologies
to improve healthcare outcomes. With its well-established healthcare
infrastructure and a growing focus on early disease detection and prevention,
the European market plays a pivotal role in shaping the future of IVD on a
global scale.
The European IVD market is a diverse landscape with a wide array of countries
actively contributing to its growth and innovation. Each of these countries
brings a unique perspective and expertise to the field, whether it’s Germany’s
technological prowess, France’s emphasis on research, the UK’s innovation in
point-of-care testing, or the precision diagnostics of the Netherlands. This
collective effort across Europe ensures that the IVD market continues to evolve,
providing cutting-edge solutions to support healthcare systems and improve
patient outcomes on the continent and beyond.
The IVD market in Germany has been gaining significant momentum in recent years.
Germany, often considered the powerhouse of Europe, has a significant presence
in the IVD market. With a well-developed healthcare infrastructure and a robust
research and development sector, Germany has been at the forefront of diagnostic
technology.
Leading companies like Siemens Healthineers and Roche Diagnostics German based
companies. These companies are known for their cutting-edge diagnostic
solutions, from clinical chemistry analyzers to molecular diagnostics, which are
widely adopted within the country and exported globally.
IN VITRO DIAGNOSTICS (IVD) MARKET - COMPETITIVE LANDSCAPE
The IVD market is highly competitive, with many key companies offering IVD
products and services. The IVD market is characterized by companies that are
continually adapting to changing dynamics. These changes are driven by the rapid
advancement of technology, the introduction of novel IVD products, and an
increasing emphasis on precise diagnostic techniques.
As the demand for advanced IVD technologies continues to grow, competition
intensifies as companies strive to offer cutting-edge products, expand their
market presence, and address evolving healthcare needs. In vitro diagnostics
vendors are pivotal players in the healthcare industry. They offer a wide array
of diagnostic tools and services, ranging from traditional laboratory
instruments to cutting-edge molecular diagnostic solutions. Their focus on
automation, connectivity, and patient-centric approaches is reshaping
healthcare, enabling more precise and rapid diagnostics.
IVD vendors offer diverse product portfolios, including instruments, reagents,
assays, and software solutions. For example, Roche Diagnostics is a leading IVD
company known for its comprehensive range of products, from blood glucose
monitors for diabetes management to advanced molecular diagnostic systems used
in cancer testing.
Vendors are constantly innovating to enhance automation and efficiency in
diagnostic processes. For instance, Beckman Coulter offers automated clinical
chemistry analyzers and immunoassay systems that streamline laboratory
workflows, reducing the risk of errors and increasing accuracy.
Leading Companies in the In Vitro Diagnostics (IVD) Market
* Hoffmann-La Roche Ltd
* Hologic Inc
* Abbott Laboratories
* Siemens AG
* Exact Sciences Corp
* bioMerieux SA
* Quidelortho Corp
* Sysmex Corp
* Bio-Rad Laboratories Inc
* Thermo Fisher Scientific Inc
* Beckman Coulter Inc
OTHER IN VITRO DIAGNOSTICS (IVD) MARKET VENDORS MENTIONED
Qiagen NV, H.U. Group Holdings Inc, and Omega Diagnostics Group Plc
Buy the Full Report to Know More About the Leading IVD Market Players
Download a Free Sample
IN VITRO DIAGNOSTICS (IVD) MARKET SEGMENTS AND SCOPE
GlobalData Plc has segmented the in vitro diagnostics (IVD) market report by
product and region:
In Vitro Diagnostics (IVD) Market Product Type Outlook (Revenue, $ Million
2021-2033)
* COVID-19 Tests
* Cholesterol Tests
* Colorectal Cancer Screening Tests
* Hepatitis B Tests
* Hepatitis C Tests
* Clinical Chemistry Analyzers
* Hematology Tests
* Human Immunodeficiency Virus (HIV) Tests
* Immunochemistry Analyzers
* Diabetes Assays
* Others
In Vitro Diagnostics (IVD) Market Regional Outlook (Revenue, $ Million,
2021-2033)
* North America
* US
* Canada
* Mexico
* Europe
* France
* Germany
* Italy
* Spain
* Netherlands
* Switzerland
* UK
* Russia
* Austria
* Belgium
* Czech Republic
* Denmark
* Greece
* Finland
* Hungary
* Ireland
* Norway
* Poland
* Portugal
* Sweden
* Turkey
* Asia-Pacific
* China
* India
* Japan
* Australia
* New Zealand
* South Korea
* Taiwan
* Central & South America
* Brazil
* Chile
* Argentina
* Middle East & Africa
* United Arab Emirates
* Saudi Arabia
* South Africa
* Israel
* Egypt
SCOPE
• This report provides overview and service addressable market for global in
vitro diagnostics (IVD) market
• It identifies the key drivers and restraints impacting growth of the IVD
market over the next 12 to 24 months.
• It includes global market forecasts for the IVD market and reimbursement
scenario, and regulatory trends.
•It covers detailed segmentation by product – COVID-19 Tests, Cholesterol Tests,
Colorectal Cancer Screening Tests, Hepatitis B Tests, Hepatitis C Tests,
Clinical Chemistry Analyzers, Hematology Tests, Human Immunodeficiency Virus
(HIV) Tests, Immunochemistry Analyzers, Diabetes Assays, and Others, along with
regional segmentation.
KEY HIGHLIGHTS
The global in Vitro Diagnostics (IVD) market will be valued at $60.3 billion in
2023 and is expected to decline temporarly at a compound annual growth rate
(CAGR) of -5.3% over the forecast period. The in vitro diagnostics market’s
future is bright, with technology, patient-centric care, and preventive
healthcare at the forefront. This industry will continue to play a crucial role
in improving healthcare outcomes and advancing medical science. IVD refers to
medical tests conducted on samples such as blood, urine, or tissues outside the
human body to diagnose various diseases and conditions. AI and machine learning
will become integral to IVD, automating image analysis and expediting diagnosis,
thereby improving workflow efficiency.
REASONS TO BUY
• This market intelligence report offers a thorough, forward-looking analysis of
the global in vitro diagnostics (IVD) market by product, regional segments in a
concise format to help executives build proactive and profitable growth
strategies.
• Accompanying GlobalData’s Forecast products, the report examines the drivers,
challenges, and regulatory trend analysis in the IVD market.
• Detailed segmentation by product – COVID-19 Tests, Cholesterol Tests,
Colorectal Cancer Screening Tests, Hepatitis B Tests, Hepatitis C Tests,
Clinical Chemistry Analyzers, Hematology Tests, Human Immunodeficiency Virus
(HIV) Tests, Immunochemistry Analyzers, Diabetes Assays, and Others, along with
vertical and regional segmentation.
• The report includes 100+ charts and tables providing in-depth analysis of the
market size, forecast, and supporting factors which are tailor-made for an
executive-level audience, with enhanced presentation quality.
• The report provides an easily digestible market assessment for decision-makers
built around in-depth information gathered from local market players, which
enables executives to quickly get up to speed with the current and emerging
trends in IVD markets.
• The competitive section of the report helps in identifying the flagbearers,
experimenters, contenders, and specialists based on their growth and innovation
performance in the IVD industry which will help stakeholders analyze competition
penetration.
• The broad perspective of the report, coupled with comprehensive, actionable
detail, will help IVD vendors and other companies succeed in the growing IVD
market globally.
KEY PLAYERS
F. Hoffmann-La Roche Ltd
Hologic Inc
Abbott Laboratories
Siemens AG
Exact Sciences Corp
bioMerieux SA
Quidelortho Corp
Sysmex Corp
Bio-Rad Laboratories Inc
Thermo Fisher Scientific Inc
Beckman Coulter Inc
TABLE OF CONTENTS
* Chapter 1 Executive Summary
* Chapter 2 Research Scope and Segmentation
* 2.1 In Vitro Diagnostics (IVD): Market Segmentation and Scope
* 2.2 In Vitro Diagnostics (IVD): Market Definitions
* Chapter 3 In Vitro Diagnostics (IVD) – Industry Trend Analysis
* 3.1 In Vitro Diagnostics (IVD) – Market Drivers
* 3.2 In Vitro Diagnostics (IVD) – Market Restraints
* 3.3 In Vitro Diagnostics (IVD) – Regulatory Landscape
* 3.4 In Vitro Diagnostics (IVD) – Reimbursement Trends
* Chapter 4 In Vitro Diagnostics (IVD) Global Outlook
* 4.1 Global In Vitro Diagnostics (IVD) Market – Revenue Snapshot ($M)
* 4.2 Global In Vitro Diagnostics (IVD): Detailed Market Size Estimates($M)
* 4.3 Global In Vitro Diagnostics (IVD) Market – By Region, 2021-2033 ($M)
* Chapter 5 In Vitro Diagnostics (IVD) Regional Outlook
* 5.1 North America In Vitro Diagnostics (IVD) Market – Overview, 2021-2033
($M)
* 5.2.1 North America In Vitro Diagnostics (IVD) Revenue by Product,
2021-2033 ($M)
* 5.2.2 US In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033 ($M)
* 5.2.3 Canada In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033
($M)
* 5.2.4 Mexico In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033
($M)
* 5.2 Europe In Vitro Diagnostics (IVD) Market – Overview, 2021-2033 ($M)
* 5.2.1 Europe In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033
($M)
* 5.2.2 France In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033
($M)
* 5.2.3 Germany In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033
($M)
* 5.2.4 Italy In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033 ($M)
* 5.2.5 Spain In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033 ($M)
* 5.2.6 The Netherlands In Vitro Diagnostics (IVD) Revenue by Product,
2021-2033 ($M)
* 5.2.7 Switzerland In Vitro Diagnostics (IVD) Revenue by Product,
2021-2033 ($M)
* 5.2.8 UK In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033 ($M)
* 5.2.9 Russia In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033
($M)
* 5.2.10 Austria In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033
($M)
* 5.2.11 Belgium In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033
($M)
* 5.2.12 Czech Republic In Vitro Diagnostics (IVD) Revenue by Product,
2021-2033 ($M)
* 5.2.13 Denmark In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033
($M)
* 5.2.14 Greece In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033
($M)
* 5.2.15 Finland In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033
($M)
* 5.2.16 Hungary In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033
($M)
* 5.2.17 Ireland In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033
($M)
* 5.2.18 Norway In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033
($M)
* 5.2.19 Poland In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033
($M)
* 5.2.20 Portugal In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033
($M)
* 5.2.21 Sweden In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033
($M)
* 5.2.22 Turkey In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033
($M)
* 5.3 Asia Pacific In Vitro Diagnostics (IVD) Market – Overview, 2021-2033
($M)
* 5.3.1 Asia Pacific In Vitro Diagnostics (IVD) Revenue by Product,
2021-2033 ($M)
* 5.3.2 China In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033 ($M)
* 5.3.3 India In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033 ($M)
* 5.3.4 Japan In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033 ($M)
* 5.3.4 New Zealand In Vitro Diagnostics (IVD) Revenue by Product,
2021-2033 ($M)
* 5.3.4 South Korea In Vitro Diagnostics (IVD) Revenue by Product,
2021-2033 ($M)
* 5.3.4 Taiwan In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033
($M)
* 5.3.4 Australia In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033
($M)
* 5.4 South & Central America In Vitro Diagnostics (IVD) Market – Overview,
2021-2033 ($M)
* 5.4.1 South & Central America In Vitro Diagnostics (IVD) Revenue by
Product, 2021-2033 ($M)
* 5.4.2 Argentina In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033
($M)
* 5.4.3 Brazil In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033
($M)
* 5.4.4 Chile In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033 ($M)
* 5.5 Middle East & Africa In Vitro Diagnostics (IVD) Market – Overview,
2021-2033 ($M)
* 5.5.1 Middle East & Africa In Vitro Diagnostics (IVD) Revenue Opportunity
by Product, 2021-2033 ($M)
* 5.5.2 United Arab Emirates In Vitro Diagnostics (IVD) Revenue by Product,
2021-2033 ($M)
* 5.5.3 Saudi Arabia In Vitro Diagnostics (IVD) Revenue by Product,
2021-2033 ($M)
* 5.5.4 South Africa In Vitro Diagnostics (IVD) Revenue by Product,
2021-2033 ($M)
* 5.5.4 Israel In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033
($M)
* 5.5.4 Egypt In Vitro Diagnostics (IVD) Revenue by Product, 2021-2033 ($M)
* Chapter 6 Competitive Landscape
* 6.1 In Vitro Diagnostics: Competitive Landscape Overview
* 6.2 In Vitro Diagnostics: Company Share Analysis
* Chapter 7 Company Profiles
* 7.1 Bio-Rad Laboratories Inc: Overview
* 7.1.1 Bio-Rad Laboratories Inc: IVD Offerings
* 7.1.2 Bio-Rad Laboratories Inc: Financials
* 7.1.3 Bio-Rad Laboratories Inc: Key Personnel
* 7.2 Hologic Inc: Overview
* 7.2.1 Hologic Inc: IVD Offerings
* 7.2.2 Hologic Inc: Financials
* 7.2.3 Hologic Inc: Key Personnel
* 7.3 Siemens AG: Overview
* 7.3.1 Siemens AG: IVD Offerings
* 7.3.2 Siemens AG: Financials
* 7.3.3 Siemens AG: Key Personnel
* 7.4 Abbott Laboratories: Overview
* 7.4.1 Abbott Laboratories: DI Offerings
* 7.4.2 Abbott Laboratories: Financials
* 7.4.3 Abbott Laboratories: Key Personnel
* 7.5 F. Hoffmann-La Roche Ltd: Overview
* 7.5.1 F. Hoffmann-La Roche Ltd: IVD Offerings
* 7.5.2 F. Hoffmann-La Roche Ltd: Financials
* 7.5.3 F. Hoffmann-La Roche Ltd: Key Personnel
* 7.6 Exact Sciences Corp: Overview
* 7.6.1 Exact Sciences Corp: IVD Offerings
* 7.6.2 Exact Sciences Corp: Financials
* 7.6.3 Exact Sciences Corp: Key Personnel
* 7.7 Thermo Fisher Scientific Inc: Overview
* 7.7.1 Thermo Fisher Scientific Inc: IVD Offerings
* 7.7.2 Thermo Fisher Scientific Inc: Financials
* 7.7.3 Thermo Fisher Scientific Inc: Key Personnel
* 7.8 Beckman Coulter Inc (Danaher Corp): Overview
* 7.8.1 Beckman Coulter Inc (Danaher Corp): IVD Offerings
* 7.8.2 Beckman Coulter Inc (Danaher Corp): Key Personnel
* 7.9 Sysmex Corp: Overview
* 7.9.1 Sysmex Corp: IVD Offerings
* 7.9.2 Sysmex Corp: Financials
* 7.9.3 Sysmex Corp: Key Personnel
* 7.10 Quidelortho Corp: Overview
* 7.10.1 Quidelortho Corp: IVD Offerings
* 7.10.2 Quidelortho Corp: Financials
* 7.10.3 Quidelortho Corp: Key Personnel
* 7.11 bioMerieux SA: Overview
* 7.11.1 bioMerieux SA: IVD Offerings
* 7.11.2 bioMerieux SA: Financials
* 7.11.3 bioMerieux SA: Key Personnel
* Chapter 10 Research Methodology
* Chapter 11 About GlobalData
TABLE
Table 1: In Vitro Diagnostics – Regulatory landscape (US and China)
Table 2: In Vitro Diagnostics – Regulatory landscape (Japan)
Table 3: In Vitro Diagnostics – Regulatory landscape (France and Germany)
Table 4: In Vitro Diagnostics – Reimbursement Scenario (US and China)
Table 5: In Vitro Diagnostics – Reimbursement Scenario (Japan)
Table 6: In Vitro Diagnostics – Reimbursement Scenario (Germany)
Table 7: In Vitro Diagnostics – Reimbursement Scenario (France)
Table 8: Global IVD Market by Region ($M), 2021-2033
Table 9: Global In Vitro Diagnostics Market Revenue, by Product ($M), 2021-2033
Table 10: North America In Vitro Diagnostics Market Revenue, by Product ($M),
2021-2033
Table 11: US In Vitro Diagnostics Market Revenue, by Product ($M), 2021-2033
Table 12: Canada In Vitro Diagnostics Market Revenue, by Product ($M), 2021-2033
Table 13: Mexico In Vitro Diagnostics Market Revenue, by Product ($M), 2021-2033
Table 14: Europe In Vitro Diagnostics Market Revenue, by Product ($M), 2021-2033
Table 15: France In Vitro Diagnostics Market Revenue, by Product ($M), 2021-2033
Table 16: Germany In Vitro Diagnostics Market Revenue, by Product ($M),
2021-2033
Table 17: Italy In Vitro Diagnostics Market Revenue, by Product ($M), 2021-2033
Table 18: Spain In Vitro Diagnostics Market Revenue, by Product ($M), 2021-2033
Table 19: Netherlands In Vitro Diagnostics Market Revenue, by Product ($M),
2021-2033
Table 20: Switzerland In Vitro Diagnostics Market Revenue, by Product ($M),
2021-2033
Table 21: UK In Vitro Diagnostics Market Revenue, by Product ($M), 2021-2033
Table 22: Russia In Vitro Diagnostics Market Revenue, by Product ($M), 2021-2033
Table 23: Austria In Vitro Diagnostics Market Revenue, by Product ($M),
2021-2033
Table 24: Belgium In Vitro Diagnostics Market Revenue, by Product ($M),
2021-2033
Table 25: Czech Republic In Vitro Diagnostics Market Revenue, by Product ($M),
2021-2033
Table 26: Denmark In Vitro Diagnostics Market Revenue, by Product ($M),
2021-2033
Table 27: Greece In Vitro Diagnostics Market Revenue, by Product ($M), 2021-2033
Table 28: Finland In Vitro Diagnostics Market Revenue, by Product ($M),
2021-2033
Table 29: Hungary In Vitro Diagnostics Market Revenue, by Product ($M),
2021-2033
Table 30: Ireland In Vitro Diagnostics Market Revenue, by Product ($M),
2021-2033
Table 31: Norway In Vitro Diagnostics Market Revenue, by Product ($M), 2021-2033
Table 32: Poland In Vitro Diagnostics Market Revenue, by Product ($M), 2021-2033
Table 33: Portugal In Vitro Diagnostics Market Revenue, by Product ($M),
2021-2033
Table 34: Sweden In Vitro Diagnostics Market Revenue, by Product ($M), 2021-2033
Table 35: Turkey In Vitro Diagnostics Market Revenue, by Product ($M), 2021-2033
Table 36: Asia-Pacific In Vitro Diagnostics Market Revenue, by Product ($M),
2021-2033
Table 37: China In Vitro Diagnostics Market Revenue, by Product ($M), 2021-2033
Table 38: India In Vitro Diagnostics Market Revenue, by Product ($M), 2021-2033
Table 39: Japan In Vitro Diagnostics Market Revenue, by Product ($M), 2021-2033
Table 40: Australia In Vitro Diagnostics Market Revenue, by Product ($M),
2021-2033
Table 41: New Zealand In Vitro Diagnostics Market Revenue, by Product ($M),
2021-2033
Table 42: South Korea In Vitro Diagnostics Market Revenue, by Product ($M),
2021-2033
Table 43: Taiwan In Vitro Diagnostics Market Revenue, by Product ($M), 2021-2033
Table 44: South & Central America In Vitro Diagnostics Market Revenue, by
Product ($M), 2021-2033
Table 45: Argentina In Vitro Diagnostics Market Revenue, by Product ($M),
2021-2033
Table 46: Brazil In Vitro Diagnostics Market Revenue, by Product ($M), 2021-2033
Table 47: Chile In Vitro Diagnostics Market Revenue, by Product ($M), 2021-2033
Table 48: Middle East & Africa In Vitro Diagnostics Market Revenue, by Product
($M), 2021-2033
Table 49: United Arab Emirates In Vitro Diagnostics Market Revenue, by Product
($M), 2021-2033
Table 50: Saudi Arabia In Vitro Diagnostics Market Revenue, by Product ($M),
2021-2033
Table 51: South Africa In Vitro Diagnostics Market Revenue, by Product ($M),
2021-2033
Table 52: Israel In Vitro Diagnostics Market Revenue, by Product ($M), 2021-2033
Table 53: Egypt In Vitro Diagnostics Market Revenue, by Product ($M), 2021-2033
FIGURES
Fig 1: Key In Vitro Diagnostics (IVD) Country Markets ($B), 2022 vs 2033
Fig 2: In Vitro Diagnostics (IVD) Market by Region, 2022 ($M)
Fig 3: In Vitro Diagnostics Market – Segmentation, Product
Fig 4: In Vitro Diagnostics Market – Segmentation, Region
Fig 5: Global In Vitro Diagnostics Market Size & Forecasts ($M), 2021-2033
Fig 6: North America In Vitro Diagnostics Market ($M), 2021-2033
Fig 7: Europe In Vitro Diagnostics Market ($M), 2021-2033
Fig 8: Asia-Pacific In Vitro Diagnostics Market ($M), 2021-2033
Fig 9: South and Central America In Vitro Diagnostics Market ($M), 2021-2033
Fig 10: Middle East and Africa In Vitro Diagnostics Market ($M), 2021-2033
Fig 11: COVID-19 Tests Key Players Market Share in 2022
Fig 12: Cholesterol Tests Key Players Market Share in 2022
Fig 13: Colorectal Cancer Screening Tests Key Players Market Share in 2022
Fig 14: Hepatitis B Tests Key Players Market Share in 2022
Fig 15: Hepatitis C Tests Key Players Market Share in 2022
Fig 16: Clinical Chemistry Analyzers Key Players Market Share in 2022
Fig 17: Hematology Tests Key Players Market Share in 2022
Fig 18: Human Immunodeficiency Virus (HIV) Tests Key Players Market Share in
2022
Fig 19: Immunochemistry Analyzers Key Players Market Share in 2022
Fig 20: Diabetes Assays Key Players Market Share in 2022
Fig 21: Bio-Rad Laboratories Inc Financial Performance (USD Million)
Fig 22: Hologic Inc Financial Performance (USD Million)
Fig 23: Siemens AG Financial Performance (EUR Million)
Fig 24: Abbott Laboratories Financial Performance (USD Million)
Fig 25: F. Hoffmann-La Roche Ltd Financial Performance (CHF Million)
Fig 26: Exact Sciences Corp Financial Performance (USD Million)
Fig 27: Thermo Fisher Scientific Inc Financial Performance (USD Million)
Fig 28: Sysmex Corp Financial Performance (JPY Million)
Fig 29: Quidelortho Corp Financial Performance (USD Million)
Fig 30: bioMerieux SA (bioMerieux) NV Financial Performance (EUR Million)
Fig 31: Research Methodology Steps
Fig 32: Core Objectives of the Market Study
Fig 33: Research Approach
Fig 34: Analysis Flow
Fig 35: Quality Control Flow
FREQUENTLY ASKED QUESTIONS
* What was the IVD market size in 2023?
The IVD market size will be valued at $60.3 billion in 2023.
* What is the IVD market growth rate?
The IVD market is expected to decline at a CAGR of -5.3% over the forecast
period (2023-2033).
* What is the key IVD market driver?
The rising demand for point-of-care (POC) testing is a prominent market
driver in the in-vitro diagnostics (IVD) industry. This paradigm shift in
healthcare diagnostics has been spurred by several key factors. POC testing
refers to medical diagnostic testing conducted outside the traditional
laboratory setting, typically near or at the patient’s location. It offers
numerous advantages, including faster results, reduced costs, and increased
accessibility to healthcare. This trend has gained significant momentum in
recent years due to various factors.
* Which will be the leading product type segment in the IVD market in 2023?
COVID-19 tests will be the leading product type segment in the IVD market in
2023.
* Which are the leading IVD companies globally?
The leading IVD companies are Danaher Corp, Abbott Laboratories, F.
Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc., and Thermo Fisher
Scientific Inc.
* Is there a third level of segmentation in the report?
GlobalData’s focus is on providing reliable and accurate data that is
supported by robust research methodology. Our reports undergo rigorous
quality checks and are based on primary and secondary research sources,
ensuring that the numbers and insights provided are trustworthy. However,
despite the best efforts to gather comprehensive data, there could be
instances where the available data is limited, making it challenging to
provide third-level segmentation. In such cases, GlobalData may choose to
provide high-level insights and general trends rather than forcing
segmentation that may not be backed by sufficient data. This approach ensures
that the report’s overall quality and credibility are maintained.
Currency USD
* Currency Conversion is for Indicative purpose only. All orders are processed
in US Dollars only.
* USD - US Dollar
* AUD — Australian Dollar
* BRL — Brazilian Real
* CNY — Yuan Renminbi
* EUR — Euro
* GBP — Pound Sterling
* INR — Indian Rupee
* JPY — Japanese Yen
* ZAR — South African Rand
Single User
$3,950
Can be used by individual purchaser only
Most Popular
Multi-users
$5,950
Can be shared by unlimited users within one corporate location e.g. a regional
office
Enterprise
$7,950
Can be shared globally by unlimited users within the purchasing corporation e.g.
all employees of a single company
Buy Now Add to Basket
--------------------------------------------------------------------------------
UNDECIDED ABOUT PURCHASING THIS REPORT?
Enquire Before Buying Request a Free Sample
GET IN TOUCH TO FIND OUT ABOUT MULTI-PURCHASE DISCOUNTS
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects
tracked, we can create a tailored dataset for you based on the types of projects
you are looking for. Please get in touch with your specific requirements and we
can send you a quote.
SAMPLE REPORT
We are confident about In-Vitro Diagnostics (IVD) Market Size, Share and Trends
Analysis by Region, Product and Segment Forecast to 2033 report's unique
quality. However, we want you to make the most beneficial decision for your
business, so we offer free sample pages to help you:
* Assess the relevance of the report
* Evaluate the quality of the report
* Justify the cost
Download your copy of the sample report and make an informed decision about
whether the full report will provide you with the insights and information you
need.
BELOW IS A SAMPLE REPORT TO UNDERSTAND WHAT YOU ARE BUYING
Click here to download sample
See what our customers are saying
GlobalData provides a great range of information and reports on various sectors
that is highly relevant, timely, easy to access and utilise. The reports and
data dashboards help engagement with clients; they provide valuable industry and
market insights that can enrich client conversations and can help in the shaping
of value propositions. Moreover, using GlobalData products has helped increase
my knowledge of the finance sector, the players within it, and the general
threats and opportunities.
I find the consumer surveys that are carried out to be extremely beneficial and
not something I have seen anywhere else. They provided an insightful view of why
and which consumers take (or don’t) particular financial products. This can help
shape conversations with clients to ensure they make the right strategic
decisions for their business.
One of the challenges I have found is that data in the payments space is often
piecemeal. With GD all of the data I need is in one place, but it also comes
with additional market reports that provide useful extra context and
information. Having the ability to set-up alerts on relevant movements in the
industry, be it competitors or customers, and have them emailed directly to me,
ensures I get early sight of industry activity and don’t have to search for
news.
Senior Account Manager, TSYS
“The GlobalData platform is our go-to tool for intelligence services. GlobalData
provides an easy way to access comprehensive intelligence data around multiple
sectors, which essentially makes it a one-for-all intelligence platform, for
tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised
services, which benefits everyday use. The highly detailed project intelligence
and forecast reports can be utilised across multiple departments and workflow
scopes, from operational to strategic level, and often support strategic
decisions. GlobalData Analytics and visualisation solutions has contributed
positively when preparing management presentations and strategic papers.”
Business Intelligence & Marketing Manager, SAL Heavy Lift
“COVID-19 has caused significant interference to our business and the COVID-19
intelligence from GlobalData has helped us reach better decisions around
strategy. These two highlights have helped enormously to understand the
projections into the future concerning our business units, we also utilise the
project database to source new projects for Liebherr-Werk to use as an
additional source to pitch for new business.”
Market Analyst & Management, Liebherr-Werk
Your daily news has saved me a lot of time and keeps me up-to-date with what is
happening in the market, I like that you almost always have a link to the source
origin. We also use your market data in our Strategic Business Process to
support our business decisions. By having everything in one place on the
Intelligence Center it has saved me a lot of time versus looking on different
sources, the alert function also helps with this.
Head of Key Accounts, Saab AB
Having used several other market research companies, I find that GlobalData
manages to provide that ‘difficult-to-get’ market data that others can’t, as
well as very diverse and complete consumer surveys.
Marketing Intelligence Manager, Portugal Foods
Our experience with GlobalData has been very good, from the platform itself to
the people. I find that the analysts and the account team have a high level of
customer focus and responsiveness and therefore I can always rely on. The
platform is more holistic than other providers. It is convenient and almost like
a one stop shop. The pricing suite is highly competitive and value for our
organisation.
I like reports that inform new segments such as the analysis on generation Z,
millennials, the impact of COVID 19 to our banking customers and their new
channel habits. Secondly the specialist insight on affluent sector significantly
increases our understanding about this group of customers. The combination of
those give us depth and breadth of the evolving market.
I’m in the business of answering and helping people make decisions so with the
intelligence center I can do that, effectively and efficiently. I can share
quickly key insights that answer and satisfy our country stakeholders by giving
them many quality studies and primary research about competitive landscape
beyond the outlook of our bank. It helps me be seen as an advisory partner and
that makes a big difference. A big benefit of our subscription is that no one
holds the whole data and because it allows so many people, so many different
parts of our organisation have access, it enables all teams to have the same
level of knowledge and decision support.
Head of Customer Insight and Research, Standard Chartered
“I know that I can always rely on Globaldata’s work when I’m searching for the
right consumer and market insights. I use Globaldata insights to understand the
changing market & consumer landscape and help create better taste & wellbeing
solutions for our customers in food, beverage and healthcare industries.
Globaldata has the right data and the reports are of very high quality compared
to your competitors. Globaldata not only has overall market sizes & consumer
insights on food & beverages but also provides insights at the ingredient &
flavour level. That is key for B2B companies like Givaudan. This way we
understand our customers’ business and also gain insight to our unique industry”
Head of Consumer Sensory Insights, Givaudan
GlobalData provides a great range of information and reports on various sectors
that is highly relevant, timely, easy to access and utilise. The reports and
data dashboards help engagement with clients; they provide valuable industry and
market insights that can enrich client conversations and can help in the shaping
of value propositions. Moreover, using GlobalData products has helped increase
my knowledge of the finance sector, the players within it, and the general
threats and opportunities.
I find the consumer surveys that are carried out to be extremely beneficial and
not something I have seen anywhere else. They provided an insightful view of why
and which consumers take (or don’t) particular financial products. This can help
shape conversations with clients to ensure they make the right strategic
decisions for their business.
One of the challenges I have found is that data in the payments space is often
piecemeal. With GD all of the data I need is in one place, but it also comes
with additional market reports that provide useful extra context and
information. Having the ability to set-up alerts on relevant movements in the
industry, be it competitors or customers, and have them emailed directly to me,
ensures I get early sight of industry activity and don’t have to search for
news.
Senior Account Manager, TSYS
“The GlobalData platform is our go-to tool for intelligence services. GlobalData
provides an easy way to access comprehensive intelligence data around multiple
sectors, which essentially makes it a one-for-all intelligence platform, for
tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised
services, which benefits everyday use. The highly detailed project intelligence
and forecast reports can be utilised across multiple departments and workflow
scopes, from operational to strategic level, and often support strategic
decisions. GlobalData Analytics and visualisation solutions has contributed
positively when preparing management presentations and strategic papers.”
Business Intelligence & Marketing Manager, SAL Heavy Lift
RELATED REPORTS
View more In Vitro Diagnostics reports
Medical Devices
New
Clinical Chemistry Analyzers Market Size by Segments, Share, Regulatory,
Reimbursement,…
$7,500 | November 2023
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory,
Reimbursement, Installed…
$7,500 | November 2023
Medical Devices
United States Surgical Energy Instruments Market Size (Value, Volume, ASP)…
$500 | November 2022
Go even deeper with GlobalData Intelligence Center
Every Company Report we produce is powered by the GlobalData Intelligence
Center.
Subscribing to our intelligence platform means you can monitor developments at
In-Vitro Diagnostics (IVD) Market Size, Share and Trends Analysis by Region,
Product and Segment Forecast to 2033 in real time.
* Access a live In-Vitro Diagnostics (IVD) Market Size, Share and Trends
Analysis by Region, Product and Segment Forecast to 2033 dashboard for 12
months, with up-to-the-minute insights.
* Fuel your decision making with real-time deal coverage and media activity.
* Turn insights on financials, deals, products and pipelines into powerful
agents of commercial advantage.
Tell me more
--------------------------------------------------------------------------------
* Hot Topics
* Terms & Conditions
* Privacy Policy
* Contact
* Sitemap
* Modern Slavery Statement
--------------------------------------------------------------------------------
Top of page
© GlobalData Plc 2023 | Registered Office: John Carpenter House, John Carpenter
Street, London, EC4Y 0AN, UK | Registered in England No. 03925319
Blockbuster
Sector Analysis
Report Detail Page
SEARCH OUR DATABASE
Trending:
Ukraine Crisis Briefing Inflation COVID-19 Sustainability Tesla Netflix Vaccine
×
Can be used by individual purchaser only
Can be shared by unlimited users within one corporate location e.g. a regional
office
Can be shared globally by unlimited users within the purchasing corporation e.g.
all employees of a single company
PRIVACY PREFERENCE CENTER
When you visit any website, it may store or retrieve information on your
browser, mostly in the form of cookies. This information might be about you,
your preferences or your device and is mostly used to make the site work as you
expect it to. The information does not usually directly identify you, but it can
give you a more personalized web experience. Because we respect your right to
privacy, you can choose not to allow some types of cookies. Click on the
different category headings to find out more and change our default settings.
However, blocking some types of cookies may impact your experience of the site
and the services we are able to offer.
More information
Allow All
MANAGE CONSENT PREFERENCES
STRICTLY NECESSARY COOKIES
Always Active
These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms. You can set your browser to block
or alert you about these cookies, but some parts of the site will not then work.
These cookies do not store any personally identifiable information.
View Vendor Details
FUNCTIONAL COOKIES
Functional Cookies
These cookies enable the website to provide enhanced functionality and
personalisation. They may be set by us or by third party providers whose
services we have added to our pages. If you do not allow these cookies then some
or all of these services may not function properly.
View Vendor Details
TARGETING COOKIES
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites. They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.
View Vendor Details
PERFORMANCE COOKIES
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site. All
information these cookies collect is aggregated and therefore anonymous. If you
do not allow these cookies we will not know when you have visited our site, and
will not be able to monitor its performance.
View Vendor Details
Back Button Performance Cookies
Vendor Search Search Icon
Filter Icon
Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label
*
View Cookies
* Name
cookie name
Confirm My Choices
WE VALUE YOUR PRIVACY
As part of GlobalData's extensive network of websites, this site is dedicated to
protecting your privacy. We may store and access personal data such as cookies,
device identifiers or other similar technologies on your device and process such
data to enhance site navigation, personalize ads and content when you visit our
sites, measure ad and content performance, gain audience insights, analyze our
site traffic as well as develop and improve our products and services. Further
information on the cookies we use and their purpose can be found on our website
privacy policy accessible here.
We use necessary cookies to make our site work. Necessary cookies enable core
functionality such as security, network management, and accessibility. You may
disable these by changing your browser settings, but this may affect how the
website functions. We'd also like to set optional cookies to help us improve our
website and help improve your experience whilst on our website.
By clicking ‘Accept All Cookies’ you agree to us enabling all optional cookies
for these purposes. Alternatively, you can set which optional cookies you wish
to enable (and update your preferences including withdrawing your consent) at
any time, by clicking ‘Cookie Settings’.
Accept All Cookies
Cookies Settings
Dismiss
GoSquared Assistant
Chat with GlobalData
GoSquared Assistant
Submit
GoSquared Assistant
Chat with GlobalData
GoSquared Assistant
Your conversation with GlobalData starts here
Unread messages
GoSquared Assistant
Drop files here to upload
3,852
Visitors
are online now
WiserNotify